Filing Details
- Accession Number:
- 0001181431-12-002267
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-01-11 17:41:04
- Reporting Period:
- 2012-01-10
- Filing Date:
- 2012-01-11
- Accepted Time:
- 2012-01-11 17:41:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070336 | Achillion Pharmaceuticals Inc | ACHN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1076979 | D Michael Kishbauch | C/O Achillion Pharmaceuticals 300 George Street New Haven CT 06511 | Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-01-10 | 90,209 | $1.60 | 90,209 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-01-10 | 90,209 | $10.01 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-01-11 | 8,900 | $1.60 | 8,900 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-01-11 | 8,900 | $12.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2012-01-10 | 90,209 | $0.00 | 90,209 | $1.60 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2012-01-11 | 8,900 | $0.00 | 8,900 | $1.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 90,209 | 2014-07-20 | No | 4 | M | Direct | |
| 81,309 | 2014-07-20 | No | 4 | M | Direct |
Footnotes
- The price in Column 4 is a weighted average price. The actual sale prices for these transactions ranged from $10.00 to $10.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- This option was granted on July 20, 2004 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
- The price in Column 4 is a weighted average price. The actual sale prices for these transactions ranged from $12.50 to $12.51. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Billionaire Hedge Funds
